Project Grant R37CA304606
- Federal Grant Award Summary Award Details: The National Cancer Institute, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded Vanderbilt University a Project Grant of $2,958,465 on September 19, 2025, for a four-year project period extending through August 31, 2029. The project aims to develop an innovative diagnostic tool to improve detection of urothelial carcinoma in situ (CIS) during bladder cancer surveillance. Products and Services: Vanderbilt University is...
- Federal Grant Award Summary Vanderbilt University received a $2.22 million Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop an augmented reality (AR) guidance system with deformation modeling for head and neck tumor resection. The project, awarded August 5, 2025, with completion targeted for July 31, 2029, addresses the clinical...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $623,432 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) awarded on May 7, 2026, with a completion date of April 30, 2031. This award supports the development and refinement of the Cancer Vision Goggle (CVG), a head-mounted fluorescence-guided surgery (FGS) system designed to improve surgical outcomes in cancer procedures by...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $449,969 Project Grant from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) effective May 1, 2026, through April 30, 2028. The award funds research to develop novel biomarkers for diagnosing malignant pleural effusion (MPE), a condition affecting approximately 200,000 individuals annually in the United States. The research leverages a diverse pleural fluid...
- Federal Project Grant Award Summary Navigation Sciences Inc. received a $225,229 Project Grant award on September 19, 2025, from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to develop EndonaviSci, an advanced navigation software system designed to improve lung cancer surgical outcomes. The software will address critical clinical challenges in performing segmentectomy—a lung-preserving surgical procedure—by enabling accurate localization...
- Federal Grant Award Summary The National Cancer Institute, under its Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded the University of Vermont & State Agricultural College a $595,012 Project Grant on April 13, 2026, with a completion date of March 31, 2031. This award supports the development and refinement of an image-enabled computational dosing model for intratumoral cisplatin delivery in non-small cell lung cancer (NSCLC) treatment. The research addresses...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a $395,973 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) on June 9, 2026, with performance completion targeted for May 31, 2028. The award funds development and validation of an augmented reality (AR) surgical guidance system designed to improve breast cancer lumpectomy outcomes by projecting volumetric magnetic resonance imaging (MRI) data...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $1,847,457 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2030. The grant supports "Building on the Foundation of the Academy of Kidney Cancer Investigators," a research initiative aimed at advancing biomedical research to transform healthcare for service members and the American public...
- Federal Project Grant Award Summary The University of Florida received a $632,670 Project Grant award from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), effective June 1, 2026 through May 31, 2031. This award supports the development of advanced artificial intelligence (AI) and decision support systems to improve renal mass diagnosis and management. The project, titled "Advancing Renal Mass Diagnosis and Management Through AI-Enhanced...
- Federal Grant Award Summary The National Cancer Institute awarded a $409,141 Project Grant to the University of California, Davis under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) for the period June 1, 2026 through May 31, 2028. The project focuses on developing and validating contrast-enhanced perfusion computed tomography (CT) as an alternative diagnostic imaging methodology for liver radioembolization treatment planning. Currently, patients undergoing selective internal...
Vanderbilt University Medical Center received a $603,714 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) awarded June 18, 2026, with a completion date of May 31, 2031. The grant supports the development of an enhanced visualization and navigational system designed to improve surgical outcomes in endoscopic treatment of upper tract urothelial carcinoma (UTUC). The primary deliverable is a technological solution that addresses the critical limitations of current endoscopic procedures, which rely on surgeons manually reconstructing three-dimensional anatomical maps from two-dimensional preoperative imaging—a process that is imprecise, highly dependent on surgeon experience, and frequently results in incomplete tumor treatment necessitating more invasive kidney removal procedures. The project directly addresses a significant clinical gap by creating tools to enhance surgical visibility and navigation during minimally invasive tumor ablation procedures. By improving the surgeon's ability to visualize tumor margins, assess pathological grade, and accurately localize tumors within the kidney's branched anatomy, the proposed system aims to make kidney-sparing endoscopic treatment more accessible and reliable across surgeons of varying experience levels. This innovation is expected to reduce the need for nephroureterectomy procedures, thereby preserving renal function and improving patient quality of life while maintaining oncologic effectiveness. The research integrates advanced imaging and navigation technologies to translate a difficult, underutilized surgical technique into a more standardized and reproducible clinical practice.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $603.7k | 6/19/26 |